1887

Abstract

A replication-defective herpes simplex virus type 1 (HSV-1) recombinant lacking the glycoprotein H (gH)-encoding gene and expressing a truncated form of the hepatitis C (HCV) E2 glycoprotein (E2-661) was constructed and characterized. We show here that cells infected with the HSV/HCV recombinant virus efficiently express the HCV E2-661 protein. Most importantly, cellular and secreted E2-661 protein were both readily detected by the E2-conformational mAb H53 and despite the high expression levels, only limited amounts of misfolded aggregates were detected in either the cellular or secreted fractions. Furthermore, cell-associated and secreted E2-661 protein bound to the major extracellular loop (MEL) of CD81 in a concentration-dependent manner and both were highly reactive with sera from HCV-infected patients. Finally, BALB/c mice immunized intraperitoneally with the recombinant HSV/HCV virus induced high levels of anti-E2 antibodies. Analysis of the induced immunoglobulin G (IgG) isotypes showed high levels of IgG2a while the levels of the IgG1 isotype were significantly lower, suggesting a Th1-type of response. We conclude that the HSV-1 recombinant virus represents a promising tool for production of non-aggregated, immunologically active forms of the E2-661 protein and might have potential applications in vaccine development.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18775-0
2003-03-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/3/vir840545.html?itemId=/content/journal/jgv/10.1099/vir.0.18775-0&mimeType=html&fmt=ahah

References

  1. Abrignani, S. & Rosa, D. ( 1998; ). Perspectives for a hepatitis C virus vaccine. Clin Diagn Virol 10, 181–185.[CrossRef]
    [Google Scholar]
  2. Brockman, M. A. & Knipe, D. M. ( 2002; ). Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity. J Virol 76, 3678–3687.[CrossRef]
    [Google Scholar]
  3. Buonocore, L., Blight, K. J., Rice, C. M. & Rose, J. K. ( 2002; ). Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76, 6865–6872.[CrossRef]
    [Google Scholar]
  4. Chien, D. Y., Choo, Q. L., Tabrizi, A. & 16 other authors ( 1992; ). Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A 89, 10011–10015.[CrossRef]
    [Google Scholar]
  5. Chien, D. Y., Choo, Q. L., Ralston, R., Spaete, R., Tong, M., Houghton, M. & Kuo, G. ( 1993; ). Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342, 933.
    [Google Scholar]
  6. Choo, Q. L., Kuo, G., Ralston, R. & 15 other authors ( 1994; ). Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 91, 1294–1298.[CrossRef]
    [Google Scholar]
  7. Choukhi, A., Ung, S., Wychowski, C. & Dubuisson, J. ( 1998; ). Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J Virol 72, 3851–3858.
    [Google Scholar]
  8. Choukhi, A., Pillez, A., Drobecq, H., Sergheraert, C., Wychowski, C. & Dubuisson, J. ( 1999; ). Characterization of aggregates of hepatitis C virus glycoproteins. J Gen Virol 80, 3099–3107.
    [Google Scholar]
  9. Cocquerel, L., Meunier, J. C., Pillez, A., Wychowski, C. & Dubuisson, J. ( 1998; ). A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72, 2183–2191.
    [Google Scholar]
  10. Cohen, J. ( 1999; ). The scientific challenge of hepatitis C. Science 285, 26–30.[CrossRef]
    [Google Scholar]
  11. Da Costa, X. J., Morrison, L. A. & Knipe, D. M. ( 2001; ). Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Virology 288, 256–263.[CrossRef]
    [Google Scholar]
  12. Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y. S., Rice, C. M. & Dubuisson, J. ( 1997; ). Formation of native hepatitis C virus glycoprotein complexes. J Virol 71, 697–704.
    [Google Scholar]
  13. Depraetere, S. & Leroux-Roels, G. ( 1999; ). Hepatitis C virus envelope proteins: immunogenicity in humans and their role in diagnosis and vaccine development. Viral Hep Rev 5, 113–146.
    [Google Scholar]
  14. Dubuisson, J. ( 1998; ). The role of chaperone proteins in the assembly of envelope proteins of hepatitis C virus. Bull Mem Acad R Med Belg 153, 343–349.
    [Google Scholar]
  15. Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell, D. G. & Rice, C. M. ( 1994; ). Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68, 6147–6160.
    [Google Scholar]
  16. Duvet, S., Cocquerel, L., Pillez, A., Cacan, R., Verbert, A., Moradpour, D., Wychowski, C. & Dubuisson, J. ( 1998; ). Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J Biol Chem 273, 32088–32095.[CrossRef]
    [Google Scholar]
  17. Flint, M., Thomas, J. M., Maidens, C. M., Shotton, C., Levy, S., Barclay, W. S. & McKeating, J. A. ( 1999; ). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 73, 6782–6790.
    [Google Scholar]
  18. Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G. R., Borrow, P. & McKeating, J. A. ( 2000; ). Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J Virol 74, 702–709.[CrossRef]
    [Google Scholar]
  19. Forns, X., Emerson, S. U., Tobin, G. J., Mushahwar, I. K., Purcell, R. H. & Bukh, J. ( 1999; ). DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface. Vaccine 17, 1992–2002.[CrossRef]
    [Google Scholar]
  20. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. & Minson, T. ( 1992; ). Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol 66, 341–348.
    [Google Scholar]
  21. Fournillier-Jacob, A., Lunel, F., Cahour, A., Cresta, P., Frangeul, L., Perrin, M., Girard, M. & Wychowski, C. ( 1996; ). Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C. J Med Virol 50, 159–167.[CrossRef]
    [Google Scholar]
  22. Hoofnagle, J. H. ( 1997; ). Hepatitis C: the clinical spectrum of disease. Hepatology 26, 15S–20S.[CrossRef]
    [Google Scholar]
  23. Hussy, P., Faust, H., Wagner, J. C., Schmid, G., Mous, J. & Jacobsen, H. ( 1997; ). Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening. J Hepatol 26, 1179–1186.[CrossRef]
    [Google Scholar]
  24. Lanford, R. E., Notvall, L., Chavez, D., White, R., Frenzel, G., Simonsen, C. & Kim, J. ( 1993; ). Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 197, 225–235.[CrossRef]
    [Google Scholar]
  25. Latchman, D. S. ( 2001; ). Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 264, 1–9.[CrossRef]
    [Google Scholar]
  26. Lauer, G. M. & Walker, B. D. ( 2001; ). Hepatitis C virus infection. N Engl J Med 345, 41–52.[CrossRef]
    [Google Scholar]
  27. Lesniewski, R., Okasinski, G., Carrick, R., Van Sant, C., Desai, S., Johnson, R., Scheffel, J., Moore, B. & Mushahwar, I. ( 1995; ). Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 45, 415–422.[CrossRef]
    [Google Scholar]
  28. Lok, A. S., Chien, D., Choo, Q. L., Chan, T. M., Chiu, E. K., Cheng, I. K., Houghton, M. & Kuo, G. ( 1993; ). Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18, 497–502.[CrossRef]
    [Google Scholar]
  29. Loudon, P. T., Blakeley, D. M., Boursnell, M. E. & 7 other authors ( 2001; ). Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. J Gene Med 3, 458–467.[CrossRef]
    [Google Scholar]
  30. Matsuura, Y., Harada, S., Suzuki, R., Watanabe, Y., Inoue, Y., Saito, I. & Miyamura, T. ( 1992; ). Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol 66, 1425–1431.
    [Google Scholar]
  31. Michalak, J. P., Wychowski, C., Choukhi, A., Meunier, J. C., Ung, S., Rice, C. M. & Dubuisson, J. ( 1997; ). Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78, 2299–2306.
    [Google Scholar]
  32. Mink, M. A., Benichou, S., Madaule, P., Tiollais, P., Prince, A. M. & Inchauspe, G. ( 1994; ). Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200, 246–255.[CrossRef]
    [Google Scholar]
  33. Miriagou, V., Argnani, R., Kakkanas, A., Georgopoulou, U., Manservigi, R. & Mavromara, P. ( 1995; ). Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice. J Gen Virol 76, 3137–3143.[CrossRef]
    [Google Scholar]
  34. Mita, E., Hayashi, N., Ueda, K., Kasahara, A., Fusamoto, H., Takamizawa, A., Matsubara, K., Okayama, H. & Kamada, T. ( 1992; ). Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease. Biochem Biophys Res Commun 183, 925–930.[CrossRef]
    [Google Scholar]
  35. Mizushima, H., Hijikata, M., Asabe, S., Hirota, M., Kimura, K. & Shimotohno, K. ( 1994; ). Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68, 6215–6222.
    [Google Scholar]
  36. Op De Beeck, A., Cocquerel, L. & Dubuisson, J. ( 2001; ). Biogenesis of hepatitis C virus envelope glycoproteins. J Gen Virol 82, 2589–2595.
    [Google Scholar]
  37. Pileri, P., Uematsu, Y., Campagnoli, S. & 8 other authors ( 1998; ). Binding of hepatitis C virus to CD81. Science 282, 938–941.[CrossRef]
    [Google Scholar]
  38. Psichogiou, M., Katsoulidou, A., Vaindirli, E., Francis, B., Lee, S. R. & Hatzakis, A. ( 1997; ). Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis. Transfusion 37, 858–862.[CrossRef]
    [Google Scholar]
  39. Reed, K. E. & Rice, C. M. ( 2000; ). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242, 55–84.
    [Google Scholar]
  40. Roizman, B. & Knipe, D. M. ( 2001; ). The replication of herpes simplex viruses. In Fields Virology, 4th edn, pp. 2399–2459. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
  41. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors ( 1990; ). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547–6549.[CrossRef]
    [Google Scholar]
  42. Sambrook, J., Fritsch, E. F. & Maniatis, T. ( 1989; ). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory.
  43. Saracco, G., Abate, M. L., Baldi, M. and others ( 1994; ). Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 14, 65–70.
    [Google Scholar]
  44. Shad, J. A. & McHutchison, J. G. ( 2001; ). Current and future therapies of hepatitis C. Clin Liver Dis 5, 335–359.[CrossRef]
    [Google Scholar]
  45. Siler, C. A., McGettigan, J. P., Dietzschold, B., Herrine, S. K., Dubuisson, J., Pomerantz, R. J. & Schnell, M. J. ( 2002; ). Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology 292, 24–34.[CrossRef]
    [Google Scholar]
  46. Tsitoura, E., Lucas, M., Revol-Guyot, V., Epstein, A. L., Manservigi, R. & Mavromara, P. ( 2002; ). Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. J Gen Virol 83, 561–566.
    [Google Scholar]
  47. Whitley, R. J. & Roizman, B. ( 2001; ). Herpes simplex virus infections. Lancet 357, 1513–1518.[CrossRef]
    [Google Scholar]
  48. Yokosuka, O., Omata, M., Ito, Y. & Ohto, M. ( 1993; ). Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. Gut 34, S64–65.[CrossRef]
    [Google Scholar]
  49. Yuki, N., Hayashi, N., Kasahara, A., Hagiwara, H., Mita, E., Ohkawa, K., Katayama, K., Fusamoto, H. & Kamada, T. ( 1996; ). Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 23, 947–952.[CrossRef]
    [Google Scholar]
  50. Zaaijer, H. L., Vallari, D. S., Cunningham, M., Lesniewski, R., Reesink, H. W., van der Poel, C. L. & Lelie, P. N. ( 1994; ). E2 and NS5: new antigens for detection of hepatitis C virus antibodies. J Med Virol 44, 395–397.[CrossRef]
    [Google Scholar]
  51. Zucchelli, S., Capone, S., Fattori, E. & 8 other authors ( 2000; ). Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 74, 11598–11607.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18775-0
Loading
/content/journal/jgv/10.1099/vir.0.18775-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error